Site: CDL-Montreal, CDL-Toronto
Stream: Artificial Intelligence, Health
Milad Alucozai invests in early-stage life sciences, healthcare, and deep tech companies. He is a Venture Partner at Entrepreneur First, a global fund that has built 300+ companies with a combined valuation of over $2 billion. He also serves as a startup mentor for groups like the Creative Destruction Lab. Milad’s career began as a bench scientist working in translational neuroscience and multiphysics labs. He transitioned into becoming a founder and part of the founding team of three different healthcare and life sciences startups. While at Accenture, he led a team of data scientists and engineers to build AI tools and services for large pharmaceutical companies and hospital networks. He is currently the CBO at Mekonos, a San Francisco based company building a platform for cell delivery supporting the future of cell and gene therapies. He also was their pre-seed investor. Milad’s career spans across North America and Europe helping startups, nonprofits, and large organizations build products customers love and helping people unlock their potential and truly thrive. As a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine, he graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program. As a George J. Mitchell Scholar, he completed graduate school in Immunology & Public Health.